Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Coexistence of immunogenic and suppressogenic epitopes in tumor cells and various types of macromolecules

  • 16 Accesses

  • 20 Citations

This is a preview of subscription content, log in to check access.


  1. 1.

    Adorini L, Harvey MA, Miller A, Sercarz EE (1979a) Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J Exp Med 150:293

  2. 2.

    Adorini L, Harvey M, Sercarz EE (1979b) The fine specificity of regulatory T cells. IV. Idiotypic complementarity and antigen-bridging interactions in the anti-lysozyme response. Eur J Immunol 9:906

  3. 3.

    Adorini L, Miller A, Sercarz EE (1979c) The fine specificity of regulatory T cells. I. Hen egg-white lysozyme-induced suppressor T cells in a genetically nonresponder mouse strain do not recognize a closely related immunogenic lysozyme. J Immunol 122:871

  4. 4.

    Ahituv A, Naor D, Sharon R, Tarcic N, Klein BY (1982) Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of Moloney virus-induced tumors in CBA and A mice. Cancer Immunol Immunother 14:16

  5. 5.

    Alaba O, Rogers MJ, Law LW (1979) Rauscher leukemia virus-induced tumor antigens: complete separation from gp70, p30 and H-2. Int J Cancer 24:608

  6. 6.

    Araneo BA, Sercarz EE (1980) MHC restriction and positive selection of T suppressor cells revealed by mixture with inducer T cells. In: Pernis B, Vogel HJ (eds) Regulatory T lymphocytes. Academic Press, New York, p 329

  7. 7.

    Araneo BA, Yowell RL, Metzger DW, Sercarz EE (1981) Positive selection of major histocompatibility complex-restricted suppressor T cells bearing the predominant idiotype in the immune response to lysozyme. Proc Natl Acad Sci USA 78:499

  8. 8.

    Brandchaft PB, Aoki T, Silverman TN (1976) Immunogenic and immunosuppressive components in soluble preparations from Moloney murine leukemia virus-induced tumor cells. Int J Cancer 17:678

  9. 9.

    Bullock WW, Katz DH, Benacerraf B (1975) Induction of T-lymphocyte responses to a small molecular weight antigen. III. T-T cell interactions to determinants linked together: suppression vs enhancement. J Exp Med 142:275

  10. 10.

    Burnet FM (1970) The concept of immunological surveillance. Prog Exp Tumor Res 13:1

  11. 11.

    Cantor H, Gershon RK (1979) Immunological circuits: cellular composition. Fed Proc 38:2058

  12. 12.

    Devens B, Galili N, Deutsch O, Naor D, Klein E (1978) Immune responses to weakly immunogenic virally induced tumors. II. Suppressive effects of the in vivo-carried tumor YAC. Eur J Immunol 8:573

  13. 13.

    Devens B, Deutsch O, Avraham Y, Naor D (1981) Immune response to weakly immunogenic virally induced tumors. IX. Mice injected with the in vitro variant of YAC tumor (YAC-1) resist lethal doses of the tumorgenic YAC cells. Immunobiology 159:432

  14. 14.

    Eichmann K (1975) Idiotype suppression. II. Amplification of a suppressor T cell with anti-idiotypic activity. Eur J Immunol 5:511

  15. 15.

    Eichmann K (1978) Expression and function of idiotypes on lymphocytes. Adv Immunol 26:195

  16. 16.

    Eichmann K, Falk I, Rajewsky K (1978) Recognition of idiotypes in lymphocyte interactions. II. Antigen-independent cooperation between T and B lymphocytes that possess similar and complementary idiotypes. Eur J Immunol 8:853

  17. 17.

    Eylar EH, Hashim GA (1968) Allergic encephalomyelitis: The structure of encephalitogenic determinant. Proc Natl Acad Sci USA 61:644

  18. 18.

    Galili N, Devens B, Naor D, Becker S, Klein E (1978) Immune responses to weakly immunogenic virally induced tumors. I. Overcoming low responsiveness by priming mice with a syngeneic in vitro tumor line or allogeneic cross-reactive tumor. Eur J Immunol 8:17

  19. 19.

    Goodman JW, Fong S, Lewis GK, Kamin R, Nitecki DE, Balian GD (1978) Antigen structure and lymphocyte activation. Immunol Rev 39:36

  20. 20.

    Greene MI, Dorf ME, Pierres M, Benacerraf B (1977) Reduction of syngeneic tumor growth by an anti-I-J alloantiserum. Proc Natl Acad Sci USA 74:5118

  21. 21.

    Gutte B, Merrifield RB (1971) The synthesis of ribonuclease A. J Biol Chem 246:1922

  22. 22.

    Harvey MA, Adorini L, Miller A, Sercarz EE (1979) Lysozyme-induced T-suppressor cells and antibodies have a predominant idiotype. Nature 281:594

  23. 23.

    Hashim GA (1978) Myelin basic protein: structure, function and antigenic determinants. Immunol Rev 39:60

  24. 24.

    Hashim GA, Eylar EH (1969) Allergic encephalomyelitis: Isolation and characterization of encephalitogenic peptides from the basic protein of bovine spinal cord. Arch Biochem Biophys 129:645

  25. 25.

    Hashim GA, Sharpe RD, Carvalho EF, Stevens LE (1976) Suppression and reversal of allergic encephalomyelitis in guinea pigs with a non-encephalitogenic analogue of the tryptophan region of the myelin basic protein. J Immunol 116:126

  26. 26.

    Hewitt HB (1978) The choice of animal tumors for experimental studies of cancer therapy. Adv Cancer Res 27:149

  27. 27.

    Hewitt HB, Blake ER, Walder AS (1976) A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumors of spontaneous origin. Br J Cancer 33:241

  28. 28.

    Hill SW, Sercarz EE (1975) Fine specificity of the H-2 linked immune response gene for the gallinaceous lysozymes. Eur J Immunol 5:317

  29. 29.

    Jandinsky JJ, Li J, Wettstein PJ, Frelinger JA, Scott DW (1980) Role of self carriers in the immune response and tolerance. V. Reversal of trinitrophenyl-modified self suppression of the B-cell response by blocking of H-2 antigens. J Exp Med 151:133

  30. 30.

    Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol (Paris) 125C:373

  31. 31.

    Kahan BD, Tanaka T, Pellis NR (1980) Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens. J Natl Cancer Inst 65:1001

  32. 32.

    Kapp JA, Pierce CW, Schlossman S, Benacerraf B (1974) Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the teropolymer l-glutamic acid60-l-alanine30-l-tyrosine10 (GAT). J Exp Med 140:648

  33. 33.

    Kibler RF, Shapira R, McKneally S, Jenkins J, Selden P, Chou F (1969) Encephalitogenic protein: structure. Science 164:577

  34. 34.

    Klein BY, Frenkel S, Ahituv A, Naor D (1980) Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. I. Screening of immunogenic components by isopycnic ultracentrifugation and polyacrylamide electrophoresis of a tumor homogenate. J Immunol Methods 38:325

  35. 35.

    Klein BY, Sharon R, Avraham Y, Ahituv A, Naor D (1983) Isolation of immunogenic entities from nonimmunogenic transplantable tumors and their normal cell counterparts. Transplant Proc 15:225

  36. 36.

    Klein BY, Sharon R, Tarcic N, Naor D (1982) Induction of antitumor reactive cells or suppressor cells by different molecular species isolated from the same nonimmunogenic tumor. Immunobiology 163:7

  37. 37.

    Kobrin BJ, Naor D, Klein BY (1981) Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic anti-tumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor. J Immunol 126:1874

  38. 38.

    Krzych U, Fowler A, Sercarz EE (1983) Antigen structures used by regulatory T cells in the interaction among T suppressor T helper and B cells. In: Celada F, Schumaker V, Sercarz EE (eds) Protein conformation as immunoligic signal. Plenum Press, London (in press)

  39. 39.

    Law LW, Rogers MJ, Appella E (1980) Tumor antigens on neoplasms induced by chemical carcinogens and by DNA- and RNA-containing viruses: properties of the solubilized antigens. Adv Cancer Res 32:201

  40. 40.

    Macek CM, Kahan BD, Pellis NR (1980) Delayed hypersensitivity to crude and partially purified murine tumor-specific transplantation antigens and alloantigens utilizing the footpad swelling assay. J Immunol 125:1639

  41. 41.

    Maizels RM, Clarke JA, Harvey MA, Miller A, Sercarz EE (1980a) Epitope specificity of the T cell proliferative response to lysozyme: proliferative T cells react predominantly to different determinants from those recognized by B cells. Eur J Immunol 10:509

  42. 42.

    Maizels RM, Clarke JA, Harvey MA, Miller A, Sercarz EE (1980b) Ir-gene control of T cell proliferative responses: two distinct expressions of the genetically nonresponsive state. Eur J Immunol 10:516

  43. 43.

    Mäkelä O (1970) Analogies between lymphocyte receptors and the resulting humoral antibodies. Transplant Rev 5:3

  44. 44.

    Martenson RE, Deibler GE, Kies MW (1970) Myelin basic proteins of the rat central nervous system. Purification, encephalitogenic properties and amino acid compositions. Biochim Biophys Acta 200:353

  45. 45.

    Mitchison NA (1971) The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur J Immunol 1:18

  46. 46.

    Möller G, Möller E (1976) The concept of immunological surveillance against neoplasia. Transplant Rev 28:3

  47. 47.

    Muckerheide A, Pesce AJ, Michael C (1977) Immunosuppressive properties of a peptic fragment of BSA. J Immunol 119:1340

  48. 48.

    Naor D (1979) Suppressor cells: permitters and promoters of malignancy? Adv Cancer Res 29:45

  49. 49.

    Pellis NR, Yamagishi H, Macek CM, Kahan BD (1980) Specificity and biological activity of extracted murine tumor-specific transplantation antigens. Int J Cancer 26:443

  50. 50.

    Pellis NR, Yamagishi H, Shulan DJ, Hahan BD (1981) Use of preparative isoelectric focusing in a sephadex gel slab to separate immunizing and growth facilitating moieties in crude 3 M KCl extracts of a murine fibrosarcoma. Cancer Immunol Immunother 11:53

  51. 51.

    Prehn RT (1976) Do tumors grow because of the immune response of the host? Transplant Rev 28:34

  52. 52.

    Rajewsky K, Schirrmacher V, Nase S, Jerne NK (1969) The requirement of more than one antigenic determinant for immunogenicity. J Exp Med 129:1131

  53. 53.

    Scott DW, Long C, Jandinski JJ, Li JTC (1980) Role of self MHC carriers in tolerance and the immune response. Immunol Rev 50:275

  54. 54.

    Senyk G, Williams EB, Nitecki DE, Goodman JW (1971) The functional dissection of an antigen molecule: Specificity of humoral and cellular immune response to glucagon. J Exp Med 133:1294

  55. 55.

    Sercarz EE, Metzger DW (1980) Epitope-specific and idiotype-specific cellular interactions in a model protein antigen system. Semin Immunopathol 3:145

  56. 56.

    Sercarz EE, Yowell RL, Turkin D, Miller A, Araneo BA, Adorini L (1978) Different functional specificity repertoires for suppressor and helper T cells. Immunol Rev 39:108

  57. 57.

    Schwartz M, Waltenbaugh C, Dorf M, Cesla R, Sela M, Benacerraf B (1976) Determinants of antigenic molecules responsible for genetically controlled regulation of immune responses. Proc Natl Acad Sci USA 73:2862

  58. 58.

    Stutman O (1975) Immunodepression and malignancy. Adv Cancer Res 22:261

  59. 59.

    Swanborg RH (1970) The effect of selective modification of tryptophan, lysine and arginine residues of basic brain protein on encephalitogenic activity. J Immunol 105:865

  60. 60.

    Swanborg RH (1973) Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein. J Immunol 111:1067

  61. 61.

    Swanborg RH (1975) Antigen-induced inhibition of experimental allergic encephalomyelitis. III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein. J Immunol 114:191

  62. 62.

    Tada T, Okumura K (1979) The role of antigen-specific T cell factors in the immune response. Adv Immunol 28:1

  63. 63.

    Terry WD (1978) Concluding remarks. In: Terry WD, Windhorst D (eds) Progress in cancer research and therapy, vol 6: Immunotherapy of cancer: present status of trials in man. Raven Press, New York, p 669

  64. 64.

    Thàze J, Waltenbaugh C, Benacerraf B (1977) Correlation between structural characteristics and immunological properties of the teropolymer l-glutamic acid60-l-alanine30-l-tyrosine10. Eur J Immunol 7:86

  65. 65.

    Tom BH, Macek CM, Subramanian C, Miller AL, Sengupta J (1983) In vitro expression of suppressogenic and enhancing activities in human colon cancer. Journal of Biological Response Modifiers (in press)

  66. 66.

    Turkin D, Sercarz EE (1977) Key antigenic determinants in regulation of the immune response. Proc Natl Acad Sci USA 74:3984

  67. 67.

    Unanue ER (1981) The regulatory role of macrophages in antigenic stimulation. II. Symbiotic relationship between lymphocytes and macrophages. Adv Immunol 31:1

  68. 68.

    Westall FC, Robinson AB, Caccam J, Jackson J, Eylar EH (1971) Essential chemical requirements for induction of allergic encephalomyelitis. Nature 229:22

  69. 69.

    Wicker L, Katz M, Krzych U, Miller A, Sercarz EE (1981) Focusing in the immune response to a protein antigen. In: Kirchner H, Resch K (eds) 14th Leucocyte Culture Conference. Elsevier/North Holland Biomedical Press, p 99

  70. 70.

    Yamagishi H, Pellis NR, Kahan BD (1979) Tumor-protective and-facilitating antigens from 3 M KCl-solubilized tumor extracts. J Surg Res 26:392

  71. 71.

    Yamagishi H, Pellis NR, Mokyr MB, Kahan BD (1980) Specific and non-specific immunologic mechanisms of tumor growth facilitation. Cancer 45:2929

  72. 72.

    Yamamoto H (1983) Isolation of immunogenic and suppressogenic glycoproteins from adenovirus type 12 hamster tumor cells. Microbiol Immunol (in press)

  73. 73.

    Yefenof E, Goldapfel M, Ber R (1982) Nonimmunogenic radiation-induced lymphoma: Immunity induction by a somatic cell hybrid. J Natl Cancer Inst 68:841

  74. 74.

    Yowell RL, Araneo BA, Miller A, Sercarz EE (1979) Amputation of a suppressor determinant on lysozyme reveals underlying T-cell activity to other determinants. Nature 279:70

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Naor, D. Coexistence of immunogenic and suppressogenic epitopes in tumor cells and various types of macromolecules. Cancer Immunol Immunother 16, 1–10 (1983). https://doi.org/10.1007/BF00199898

Download citation


  • Tumor Cell
  • Cancer Research
  • Macromolecule